Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Review of Targeted Therapeutic Options for BRAF-Mutated Metastatic Colorectal Cancer, Including Combination Therapies

Program Overview

In this module, Benny Johnson, DO, along with Scott Kopetz, MD, PhD, course chair, will analyze targeted therapeutic options for BRAF-mutated metastatic colorectal cancer, with a focus on combination therapies. The faculty will highlight the pathway to precision therapy for BRAFV600E mutant metastatic colorectal cancer (mCRC), debating the clinical implications of recent trial data in an interactive panel ...
View Course
Update on Optimal Biomarker and Genomic Testing for Colorectal Cancer, Including BRAF Mutations

Program Overview

In this module, Christopher Lieu, MD, along with Scott Kopetz, MD, PhD, course chair, will first discuss the current landscape of genomic testing for metastatic colorectal cancer (mCRC), highlighting the changes in the last decade. Following, the faculty will analyze testing options, covering topics such as gene sequencing, genomic profiling and liquid biopsy and circulating tumor DNA. To ...
View Course
Novel Treatment Strategies for Sphingosine-1-Phosphate Therapeutics to Manage Patients with Moderate to Severe Ulcerative Colitis

Program Overview

This CME/CE activity will highlight novel treatment strategies for sphingosine-1-phosphate (S1P) therapeutics to manage patients with moderate to severe ulcerative colitis (UC). The expert faculty, led by Dr. David T. Rubin, will first review the need for new therapeutics in ulcerative colitis, including treatment goals and unmet needs. Next, the faculty will analyze the science of S1P receptor ...
View Course
Applying S1P Therapeutics to Improve Outcomes for Patients with Moderate to Severe Ulcerative Colitis

Program Overview

This CME activity is derived from content presented at the Digestive Disease Week (DDW) 2021 Virtual Meeting. The expert faculty will highlight sphingosine-1-phosphate (S1P) therapeutics to improve outcomes for patients with moderate to severe ulcerative colitis (UC). Additionally, a review of S1P receptor modulators as a therapeutic target to support the management of ulcerative colitis will be discussed ...
View Course

Upcoming Events

ASHP Midyear Clinical Meeting and Exhibition

December 6th, 2022

ESMO Immuno-Oncology Congress 2022

December 7th – 9th, 2022

Florida Society of Neurology Annual Meeting

January 6th – 7th, 2023

Advanced Curriculum for Multiple Sclerosis 2023

February 21st – 22nd, 2023